B-cell non-Hodgkin's lymphomas (NHL-B) have been difficult to establish in long-term cell culture using standard techniques. We report the establishment of five representative cell lines from high grade NHL-B using B-cell growth factor (BCGF). The five NHL-B cell lines display the morphologic, immunophenotypic, genotypic, and biologic characteristics of the lymphoma cells present in the original diagnostic specimen. The cell lines showed at least a sevenfold dose-dependent increase in proliferation in vitro over background in the presence of BCGF. Other putative B-cell growth-stimulating cytokines showed no significant proliferative activity or were inhibitory in some cases. NHL-B cell lines secreted growth factor(s) into culture supernatants HE NON-HODGKIN'S lymphomas (NHL) are a het-
marrow aspirations, fine needle aspirations (FNA) from involved lymph nodes, and body cavity fluids containing lymphoma cells. The specimens were usually obtained at the time of initial biopsy or when the patient presented in relapse. A brief description of the patients from which the cell lines were derived is presented in Table 1 .
Patient samples were studied for histopathologic type of lymphoma, using the International Working Formulation (IWF)* and modified Rappaport' classifications by comparing initial cell suspension cytospin (Shandon Southern, Pittsburgh, PA) preparations with the permanent biopsy paraffin sections, or from the cytologic prepared specimens in the case of fluids or aspirations. Immunophenotypic analysis of single cell suspensions were performed as previously described, using standard T and B lymphocyte-associated panels of murine monoclonal antibodies (MoAbs)." Neoplastic B lymphoid cell populations stained for immunofluorescence were analyzed either by fluorescence microscopy (Leitz Orthoplan with Ploem illumination) or using flow cytometry (Becton-Dickinson Fluorescence Analyzer, B-D FACS systems, Mountainview, CA). Immunophenotypic profiles of the established cell lines are also shown in Table 1 .
Cell cultures were enriched for mitotic cells by a 4OC cold shock inhibition of growth and subsequent release by incubation at 37OC. Aliquots were harvested after 16 hours at 2-to 4-hour intervals, using 0.004 pg/mL colcemid for 15 minutes to disrupt spindles. Cells were exposed to hypotonic KCl (0.075 mol/L) for 20 minutes followed by several changes of fixative (methanokacetic acid, 3:l). Air dried slides were made from the cell suspension. Harvests showing the optimal mitotic indices were banded using conventional Q, G, and C banding techniques (Trent et al, 1986)." Karyotypes are described according to ISCN nomenclature (1985) .'* Single cell suspensions from biopsy or fluid specimens were depleted of T cells by sheep red blood cell (SRBC) E rosetting, and of mononuclear cells (mostly monocytes and/or macrophages) as previously described! The SRBC negative (E-), nonadherent cell population was cell surface-phenotyped, karyotyped, and prepared for cell culture. Duplicate cell cultures were established in RPMI 1640 media (Irvine Scientific, Irvine, CA) and 20% fetal calf serum (FCS; Hyclone, Logan, UT). BCGF (12 Kd) was used either in the partially purified state as purchased from Cellular Products Inc (Buffalo, NY) or further purified to homogeneity as described by Mehta et Cell cultures were fed twice weekly and monitored for cell growth, cell viability, and growth factor dependence as previously de~cribed.'~ Cell lines were monitored for mycoplasma infection on a regular schedule.
Monoclonality of neoplastic B cells was assessed by standard Ig gene rearrangement analysis essentially as described by Cleary et al," using Southern blot analysis for DNA restriction fragments from BamHI and Hind111 digestions for JH for IgH, and CK and/or CX for IgL.
Growth factor studies. Tumor cells from the various cell lines were assessed for reactivity to various lymphokine growth factors associated with human lymphocyte growth and differentiation at the initial time of procurement, and after varying lengths of time in vitro. The growth factors used were human BCGF, as described above and, recombinant interleukin-216 (rIL-2; a gift from Dr P. Ralph of the Cetus Corp, Emeryville, CA). Other recombinant human cytokines included IL-4 (BSF-I), IL-6 (purchased from Genzyme, Boston, MA), and recombinant lymphotoxin (LT; obtained from Genentech, South San Francisco, CA). Cell lines were also studied for the production of autocrine type B-cell growth factors by collecting culture supernatants from lymphoma cell lines grown in low (fetal calf serum [FCS] 5%) or serum-free conditions (Nutridoma, Boehringer Mannheim, Indianapolis, IN) as previously de~cribed."*~* Target cells for assessing autocrine and/or BCGF activity were the lymphoma cell line cells and BCGF-dependent normal human B cell lines (BD-9, RS-1, etc).I4
Cell culture.
Immunoglobulin gene rearrangement studies.
Southern blot analysis for the presence of EBV genome in lymphoma cell lines. High molecular weight DNA from each of the lymphoma cell lines (10 pg) was digested with the restriction endonuclease BamHI, size-fractionated in 0.8% agarose gel, and transferred to a nitrocellulose filter. The filter was hybridized to an EBNA 1 probe (pEBNA) oligolabeled with P3* to a specific activity of 1 x lo9 cpm/pg. The filter was washed under high stringency conditions and exposed on X-ray film for 24 hours at 70°C.
In vitro immunoglobulin secretion by lymphoma cells. Constitutive secretion of immunoglobulins was assayed for by measuring IgM and IgG levels in cell culture supernatants at 48 or 72 hours in vitro. These assays were performed using a standard micro-enzyme linked immunosorbent assay (ELISA) method." Table 2 . where it can be observed that RCGF ( 1 2 Kd) stimulates a strong proliferative response. while the other cytokines show only weak reactivity.
RESULTS

Establishment of human NHL-B cells in vitro.
Large cell lymphomus. B-cell type. Large cell lymphomas are a heterogenous group of tumors. arising either as spontaneous lymphomas or as transformed variants of primary small cell R-cell lymphomas or B a l l chronic lymphocytic leukemias. as in Richter's syndrome. In the present study, three of the cell lines that were derived represented dimerent histopathologic subtypes (eg. large noncleaved cell, immunoblastic. etc) of large cell lymphoma. While the tumors showed some morphologic (Fig I A and R) and immunophenotypic heterogeneity. typical of these lymphomas. they also usually displayed quite stable nonrandom chromosomal abnormalities (NRCA) associated with NHL-R, as shown in Figs 3 through 5. In these cell lines. the cell surface immunophenotype and karyotype remained stable in vitro for at least 1 year.
Pre-B-cell leukemiu/lymphomu. The cell line repotted here (RT) was derived from the bone marrow of a 14-yearold patient with the pre-€3 cell type of acute lymphocytic leukemia (ALL) with peripheral lymph node involvement. The tumor cells from the initial bone marrow aspirate were typical ALL blasts morphologically and immunophenotypically (Table I) . The tumor cells responded actively to exogenous BCGF on initial exposure, and have continued to respond vigorously to the growth factor for more than a year in vitro ( Table 2 ). The ALL cells had a variety of characteristic cytogenetic abnormalities in the original diagnostic sample that are also present in the cell line (Fig 6) .
NRCA associated with the various histopathologic subtype diagnoses have become important parameters in the characteri7stion of NHL-B. The cell lines described here all demonstrated characteristic NRCA. primarily of the t(14;18) and t(8;14) type in the fresh biopsy specimens. as well as in the subsequent cell line (Figs 2 through 6 ). The NRCA were concordant in all of the cell lines reported here. In addition to the NRCA, a variety of apparent random chromosomal abnormalities were also identified in the various cell lines (Figs 2 through 6) .
In addition to providing the initial stimulatory conditions necessary for the establishment of in vitro cell growth in these cell lines. BCGF ( 1 2 Kd) sensitivity has been maintained for more than I year. Besides retaining growth factor sensitivity. the cell lines also produced a BCGF growth factor activity in the culture supernatants. This growth factor activity displayed autostimulatory Growth focror studies.
Cytogenetic obnormolities. (2) (qJ. +dd(3) (q,,),  +dol (3) (q,,). dd41 t(l.41 (qa:, , ) . t(8: 22) k,.;q,, I wamluthm 10%. dent human T cells or T-ALL cells in vitro when exposed to supernatant from the k l l lymphoma cell lines.
Due to the ubiquitow nature of EBV expression in most well-known human B-cell lymphoma cell lines (particularly Burkitt's lymphoma cell lines). our cell lines w e n evaluated for EENA-I by Southern blot analysis. In the five lines studied. two were positive and thrce were negative (Fig 7) . hensive immunophenotypic analysis of any group of human tumors.'' When such extensive immunophenotyping is combined with genotypic analysis by current cytogenetic and molecular techniques.'* the resulting biologic data base is probably the most comprehensive available for any type of human tumor. Such a comprehensive data base for tumor cell characterization can in turn allow for correlation with a wide variety of experimental parameters.
Given the experimental potential of human NHL systems, the availability of long-term cell lines from representative subtypcsof NHL-B should be particularly useful in delineating the biology of these lymphomas. Since studies by many groups, including our own, have shown that NHL cells do not usually grow spontaneously in vitro. under standard in vitro culture conditions for human lymphoid cells.*"?' the use of exogenous lineage-specific growth factor (BCGF) for initial growth stimulation is of considerable importance from a technical perspective. Our studies over the past 2 years have indicated that we could grow the majority (-70%) of fresh NHL-B for at least 4 weeks in vitro in a growth factordependent manner. It has been possible to establish a significant number of the intermediate and high grade (aggressive) NHL-B into long-term cell lines that subsequcntly become independent of exogenously provided BCGF, due at least in part to the secretion of a BCGF-like autocrine growth factor molecule by the lymphoma
We have used one of these cell lines to purify and characterize this growth factor molecule. which cross-reacts with the high molecular weight (70 Kd) intracellular BCGF molecule found in normal human T lymphocytes.'" These findings imply that the gene for RCGF, which is not usually expressed in normal B cells but which is apparently turned on in EBV-transformed lymphoblastoid cell lines." is activated in the high grade NHL-R. Preliminarystudieson these NHL-B cell lines. using the cDNA for the 12 Kd BCGF gene.'? indicate that this may in fact be the case.*'
A further consideration involves the issue of BCGFs in general, which has sparked considerable controversy recently. A rather wide array of cytokines. including IL-2. IL-4. IL-6. and LTN" in particular, have been reported to stimulate proliferation in human B cells of one source or another. We have tested all of these (as well as a wide spectrum of other natural products and recombinant cytokines on NHL-B). both from freshly plated biopsy specimens and on established NHL-B cell lines (data not shown), and find significant and reproducible growth stimulation only by low ( I 2 Kd) and/or high (60 Kd) RCGF. Another consideration has been the role of the CD23 antigen and other agonistic MoAbs in human B cell growth stimulation.?0." The NHL-R cells and cell lines that have e x p r d EBNA-I in our experience have shown moderate amounts of 'H-TdR incorporation in vitro after stimulation with anti-CD23 MoAb. but have not been able to support tumor cell growth in vitro. Those NHL-R that have been ERNA negative (greater than 50%) have been CD23 negativeon immunophenotypic analysis and have shown neither 'H-TdR incorporation nor cell growth in vitro in the presence of anti-CD23 MoAb.
The presence of EBNA negative NHL-B cell lines suggests again, as in the Rurkitt lymphoma cell lines previously describcd that have shown the lack of expression of this antigen. that transformation is not necessary for establish- 
